Filtrer vos résultats
- 3
- 1
- 3
- 1
- 4
- 1
- 1
- 1
- 1
- 4
- 4
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 4
- 3
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
triés par
|
|
Treatment of Bone and Joint Tuberculosis in France: A Multicentre Retrospective StudyJournal of Clinical Medicine, 2020, 9 (8), 12 p. ⟨10.3390/jcm9082529⟩
Article dans une revue
hal-03591322v1
|
||
|
Clinical Features and Outcome of Multidrug-Resistant Osteoarticular Tuberculosis: A 12-Year Case Series from France.Microorganisms, 2022, 10 (6), ⟨10.3390/microorganisms10061215⟩
Article dans une revue
hal-03711168v1
|
||
Adverse events during treatment of nontuberculous mycobacterial lung disease: do they really matter?28. International Congress of the European-Respiratory-Society (ERS), European Respiratory Society, Sep 2018, Paris, France. pp.PA2664, ⟨10.1183/13993003.congress-2018.PA2664⟩
Communication dans un congrès
hal-03591331v1
|
|||
|
Management of patients with pulmonary mycobacteriosis in France: a multicenter retrospective cohort studyBMC Pulmonary Medicine, 2021, 21 (1), ⟨10.1186/s12890-021-01701-5⟩
Article dans une revue
hal-03471661v1
|